Back

Ambrisentan reverses the prosenescent and anti-autophagic effect of high glucose on human pulmonary artery endothelial cells exposed to hypoxia

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Molecular modifiers of pulmonary vascular disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Filippo Biondi

(Italy)

7 More presentations in this session

Presentation thumbnail
CILP1 and NTproBNP in pulmonary hypertension and right ventricular pressure overload: a translational experimental study
Doctor A. Garcia-Alvarez (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Recruitment of CCR5-positive T cells in pulmonary vascular lesions in idiopathic- and connective tissue disease associated- pulmonary arterial hypertension
Doctor K. Ohta-Ogo (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Comprehensive bioinformatic analysis identified m6A methylation as an important regulator in mediating immune response during idiopathic pulmonary arterial hypertension
Doctor N. Liu (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Improved prognosis prediction of idiopathic pulmonary arterial hypertension using targeted plasma proteomics in disease management
Doctor Y. Yang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
PEDF upregulated in Ngfr-positive cells suppresses proliferation of pulmonary artery smooth muscle cells
Doctor C. Goten (Kanazawa, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular modifiers of pulmonary vascular disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Ambrisentan retains its pro-autophagic activity on human pulmonary artery endothelial cells exposed to hypoxia in an in vitro model mimicking diabetes
thumbnail
Congress Presentation
Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)
thumbnail
Congress Presentation
Pathobiological characterization of pulmonary hypertension associated with heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources